The Cambridge Centre for Neuropsychiatric Research
The Bahn laboratory is conducting an extensive research program to define the molecular basis of major neuropsychiatric disorders. Our focus is on schizophrenia, bipolar affective disorder, major depressive disorder and autistic and anxiety spectrum disorders.
The internationally recognized scientific team is supported by state of the art laboratory facilities at the Department of Chemical Engineering and Biotechnology, Cambridge. The Cambridge Centre for Neuropsychiatric Research (CCNR), under the direction of Prof Sabine Bahn conducts and coordinates fundamental and applied research into the causes and treatment of major neuropsychiatric disorders, focusing on biomarkers and novel target discovery with the mission to translate research findings from the bench to the patient bedside.
The Bahn lab has received generous support and funding through the Stanley Medical Research Institute (SMRI) and is a long-term partner in the Stanley Program for Epidemiology, Prevention and Treatment of Schizophrenia (SPECTS).
"CCNR starts and ends with patients"